Skip to main content
NCBI home page
Frontiers in Behavioral Neuroscience logoLink to Frontiers in Behavioral Neuroscience
. 2022 Mar 4;16:829274. doi: 10.3389/fnbeh.2022.829274

Considerations of Timing Post-ovariectomy in Mice and Rats in Studying Anxiety- and Depression-Like Behaviors Associated With Surgical Menopause in Women

Juan Francisco Rodríguez-Landa 1,*
PMCID: PMC8931748  PMID: 35309685

Introduction

Menopause is a clinical term that indicates the end of the reproductive period of women that occurs naturally; however, it can be induced by bilateral oophorectomy, which is commonly referred to as surgical menopause. Both types of menopause in women are characterized by low plasma levels and brain concentrations of estradiol and progesterone, and a marked increase in follicle-stimulating hormone (FSH) levels. This likely affects several brain neurotransmitter systems and some peripheral physiological processes, impacting the quality of life of women (Monteleone et al., 2018; Giannini et al., 2021). In addition, the long-term absence of steroid hormones is associated with physiological changes that predispose women to genitourinary, cardiovascular, osseous, and mood disorders (Giannini et al., 2021). While such changes occur gradually and require a long time to stabilize in natural menopause, they are established in a shorter time in surgical menopause, thereby influencing the severity of symptoms in comparison to natural menopause (Rodríguez-Landa et al., 2015; Kingsberg et al., 2020; Giannini et al., 2021).

In preclinical research, ovariectomy performed on mice and rats is used as a surgical menopausal model to study the effects of permanent reduction in the levels of steroid hormones. This model has been used for studying the effects of surgical menopause on the central nervous system, which is responsible for cognitive deterioration, irritability, anxiety- and depression-like behaviors (Zakaria et al., 2019; Georgieva et al., 2021). In this way, the present article discusses the influence of time post-ovariectomy on hormonal, neurochemical, and neuroanatomical changes in rodents and its relation with anxiety- and depression-like behaviors that have been reported among women subjected to bilateral oophorectomy. This would help in enhancing the understanding of behavioral changes associated with surgical menopause and help evaluate potential pharmacological strategies to ameliorate the negative effects produced by long-term ovariectomy.

Menopause, Anxiety, and Depression Symptoms

Throughout the reproductive life of the human female, significant changes in the peripheral and central concentrations of estradiol and progesterone have been reported. These hormonal changes interfere with their physiological, endocrine, and neurochemical processes, and often have negative implications on their quality of life (Kingsberg et al., 2020). Reduced concentrations of estradiol and progesterone during the premenstrual, postpartum, and menopausal periods predispose women to anxiety and depressive symptoms (Albert et al., 2015). Generally, natural menopause occurs at 45–55 years of age and indicates the end of the reproductive period in women. However, surgical menopause, which is artificially induced by bilateral oophorectomy (Rodríguez-Landa et al., 2015), also exists as an option. Oophorectomy is recommended to women for averting the potential development of estrogen-dependent ovarian/breast cancer or to reduce pain from endometriosis (Kingsberg et al., 2020). Both types of menopause are known to predispose women to neuropsychiatric disorders (Georgieva et al., 2021), which is attributed to low concentrations of estradiol, progesterone, and their reduced metabolites such as allopregnanolone, among others (Zsakai et al., 2016).

Clinical studies have shown that women who undergo bilateral oophorectomy develop physiological and psychological changes similar to those that occur with natural menopause. One report suggest that women can immediately develop symptoms of severe anxiety that impair their quality of life (Chung-Park, 2006). The emotional and affective symptoms associated with surgical menopause vary among women; however, it has been reported that performing bilateral oophorectomy before natural menopause is associated with the development of anxiety and depression disorders and an increased risk in cognitive impairment, compared with women who experience natural menopause (Rocca et al., 2018; Olmos-Vázquez et al., 2020). Rocca et al. (2018) reported an increased long-term risk of depression and anxiety symptoms in women who underwent bilateral oophorectomy, which was principally associated with estrogen deficiency. Interestingly, the incidence of anxiety symptoms in bilateral oophorectomized women was higher in the long-term as compared to that of non-oophorectomized women, which exponentially increased as time post-oophorectomy passed, even, 10, 20, and 30 years after the removal of both ovaries. As such, preclinical and clinical studies are required to understand the neurobiological bases of the disorders associated with surgical menopause in the long-term, thus enabling the evaluation of new therapeutic strategies to ameliorate symptoms and improve the quality of life of this particular group of women. In this case, neuroendocrine changes produced by long-term ovariectomy should be considered when this surgical procedure is used for evaluating the disorders associated with surgical menopause and their potential treatments.

Effects of Long-Term Ovariectomy on Anxiety- and Depression-Like Behavior

It is important to emphasize that multiple changes in the levels of diverse hormones and other substances (e.g., estradiol, progesterone, testosterone, cortisol, prolactin, insulin, glucose, and lipids) occur during natural or surgical menopause in the human female (Huerta et al., 1995; Kingsberg et al., 2020), which contribute to multiple symptoms associated with menopause. However, the most significant changes in natural or surgical menopause among women include a decrease in early cycle inhibin B and anti-Müllerian hormone levels. The decline in inhibin B produces an increase in FSH levels, which regulate the production of estradiol. Therefore, in menopausal women, FSH levels are markedly raised, and estradiol levels are significantly lowered (Burger et al., 2007; Kingsberg et al., 2020); these are associated with characteristic symptoms during menopause. Nonetheless, these hormonal changes are different between natural and surgical menopause. These changes occur gradually in natural menopause, while in surgical menopause, they occur in a shorter time.

In preclinical research, ovariectomy is a surgical procedure that involves the removal of one or both ovaries in females, which in the medium- and long-term significantly reduces plasma and brain concentrations of steroid hormones and other molecules that negatively impact brain function (Alagwu and Nneli, 2005). Interestingly, in ovariectomized mice and rats, similar hormonal changes to those of the human female occur. The FSH levels are increased as more time passes following ovariectomy, which is higher at 4 weeks than at 1–2 weeks (Moiety et al., 2015). Contrarily, progesterone and estradiol levels are undetectable at 3 months and 15 months post-ovariectomy, respectively, and they are lower at 4 weeks, than they are at 1–2 weeks post-ovariectomy (de Chaves et al., 2009; Moiety et al., 2015).

It has been reported that apparition of anxiety- and depression-like behavior associated with ovariectomy depends on the time elapsed after the procedure. For instance, the incidence of anxiety-like behavior was higher in rats at 12 weeks than at 3 weeks post-ovariectomy (Picazo et al., 2006); however, a limitation of this study was that these results were not compared with those of non-ovariectomized rats. Interestingly, 1 week post-ovariectomy did not produce significant changes on anxiety-like behavior with respect to non-ovariectomized rats; however, 3 weeks post-ovariectomy, a high incidence of anxiety-like behavior was detected in comparison with that of rats in the proestrus-estrus phase. This effect was similarly detected in rats at 6, 9, 12, and 15 weeks post-ovariectomy (Puga-Olguín et al., 2019), which coincides with estradiol and progesterone levels reduction. It was reported that rats at 12 weeks post-ovariectomy were more responsive to diazepam, an anxiolytic drug, than rats at 3 weeks post-ovariectomy (Picazo et al., 2006). This emphasizes the importance of considering the time post-ovariectomy in the evaluation of anxiety-like behavior and the effect of anxiolytic drugs.

Moreover, in the forced swim test an increase in the time of immobility was detected 2 weeks post-ovariectomy (Fedotova et al., 2016). Contrarily, Puga-Olguín et al. (2019) did not detect depression-like behaviors (increased time of immobility) in rats at 1 and 3 weeks post-ovariectomy, with respect to non-ovariectomized rats. Nonetheless, rats from 6 weeks post-ovariectomy significantly increased the incidence of depression-like behavior, with respect to rats in proestrus-estrus and metestrus-diestrus phases, and this effect was similar in rats at 9, 12, and 15 weeks post-ovariectomy.

As mentioned above, the time post-ovariectomy in mice and rats plays a significant role in the expression of anxiety- and depression-like behavior, which can be partially explained by the hormonal, neurochemical, and neuroanatomical changes associated with ovariectomy in the long term. It is noteworthy that all these changes are simply an overview of how hormones affect the brain in the context of anxiety and depression symptoms, but we cannot disregard the other physiological changes that may influence symptoms related to menopause.

Effects of Long-Term Ovariectomy on Follicle-Stimulating Hormone and Steroid Hormones in Rats and Mice

Early studies have explored endocrine changes associated with ovariectomy in rats and mice. Particularly in rats, 2 weeks post-ovariectomy, the plasma concentrations of estradiol and progesterone did not differ significantly from the basal conditions (Ratka and Simpkins, 1990). However, 3 weeks post-ovariectomy, there was a significant reduction in estradiol and progesterone levels and an increase in luteinizing hormone and FSH levels in plasma (Wise and Ratner, 1980). To note, the reduced concentration of estradiol after 2 weeks post-ovariectomy remained until 7 weeks when the study ended (Li et al., 2014). Six weeks post-ovariectomy, a significant reduction in the plasma levels of progesterone, estradiol, and testosterone was detected in rats (Alagwu and Nneli, 2005).

On the other hand, Moiety et al. (2015) evaluated the effects at 1 and 4 weeks after hysterectomy and unilateral and bilateral ovariectomy on FSH and estradiol levels in rats. With respect to the baseline, FSH levels increased approximately to 26.19 and 73.81%, after 1 and 4 weeks post-hysterectomy, respectively. One week post unilateral ovariectomy, FSH levels increased approximately to 44.68%, while after 4 weeks FSH increased to ~80.85% with respect to the baseline. Interestingly, a more significant effect on FSH levels was observed when bilateral ovariectomy was performed. In this case, 1 week post bilateral ovariectomy FSH levels significantly increased to approximately 91.11% vs. the baseline, but more significant effects were detected after 4 weeks, increasing FSH approximately to 222.22% with respect to the baseline. As for the concentration of estradiol at 1 week post hysterectomy, a slight reduction of ~5.21% was noted, while 4 weeks after, estradiol levels were reduced to ~16.94%, compared with the baseline. One week after the unilateral ovariectomy, estradiol was reduced to 7.26%, while 4 weeks after it was reduced to ~29.19%, with respect to the baseline. Interestingly, when bilateral ovariectomy was performed, the concentration of estradiol was reduced to ~21.45% of the baseline. However, estradiol was further reduced to 60.81% 4 weeks post bilateral ovariectomy with respect to the baseline. Importantly, the greater effects on FSH and estradiol were produced after 4 weeks of bilateral ovariectomy, followed by unilateral ovariectomy and hysterectomy. These results are consistent with those of previous studies that found a significant reduction in plasma concentrations of estradiol and testosterone at 4 weeks post-ovariectomy and was undetectable at 24 weeks post-ovariectomy (Zhao et al., 2005). The same effect was detected in rats at 3 months and 15 months post-ovariectomy (de Chaves et al., 2009).

Despite few studies on endocrine changes occurring in ovariectomized mice, it has been reported that after 4 days and 1 week post-ovariectomy, the concentrations of FSH are significantly increased with respect to intact cycling mice (Bronson, 1976; Chandrashekar and Bartke, 1996; Xu et al., 2000), but greater effects are detected after 2–4 weeks post-ovariectomy (Rodin et al., 1990), as it occurs in ovariectomized rats. Accordingly, after 2–14 weeks post-ovariectomy in mice, serum estradiol levels were significantly decreased by approximately 31% with respect to the sham-operated mice, which was accompanied by a significantly increased concentration of FSH (Park et al., 2014; Lee et al., 2020; Canuas-Landero et al., 2021). These data clearly show the importance of considering and standardizing the post-ovariectomy time frame to identify behavioral and hormonal changes associated with this surgical manipulation, thus avoiding erroneous interpretation of results and compare results from different laboratories.

Neuroanatomical and Neurochemical Changes Associated with Long-Term Ovariectomy: Effects on Anxiety and Depression-Like Behavior

The lower concentrations of progesterone and estrogen that occur during surgical or natural menopause produce an imbalance in neurochemical brain communication that subsequently affects neurotransmitter pathways (Smith et al., 1998; Rodríguez-Landa et al., 2015; García-Ríos et al., 2017; Kingsberg et al., 2020), wherein reduced concentrations of dopamine, serotonin, androstenedione, testosterone estradiol, GABA, β-endorphin, and allopregnanolone, and increased concentrations of noradrenaline and cortisol, among others, have been reported (Monteleone et al., 2018). All these changes produce neuroanatomical modifications in brain structures involved in anxiety and depression such as the raphe nucleus, hippocampus, and cerebral cortex (Monteleone et al., 2018).

In experimental research, bilateral ovariectomy in rats has also been used to evaluate the effects of the post-ovariectomy time frame on anxiety- and depression-like behavior, as well as the effect of anxiolytic and antidepressant compounds under these experimental conditions (Table 1). However, different post-ovariectomy time frames in mice and rats have been used, which can hinder the comparison of the results of different studies. Therefore, it is important to establish the different changes associated with the time of post-ovariectomy in rodents.

Table 1.

Effects of timing post-ovariectomy and some pharmacological treatments on anxiety- and depression-like behaviors in mice and rats.

Effects of ovariectomy and anxiolytic drugs on anxiety-like behavior
Subjects/Weeks post-OVX OVX effect/Test Treatment Treatment effect Inline graphic References
NMRI mice/1 ne/EPM – – Galeeva and Tuohimaa, 2001
Wistar rats/1 ne/EPM – – Puga-Olguín et al., 2019
Sprague-Dawley rats/2 ne/OFT – – Hiroi and Neumaier, 2006
C57BL/6 mice/2 ne/CUS+EPM – – Lagunas et al., 2010
Wistar rats/3 ne/EPM – – Marcondes et al., 2001
Wistar Rats/8 Inline graphic/EPM – – Dornellas et al., 2018
Wistar rats/3,6,9,12,15 Inline graphic/EPM – – Puga-Olguín et al., 2019
Sprague-Dawley rats/4 Inline graphic/EPM – – Zoladz et al., 2019
C57BL/6 mice/16 Inline graphic/CUS+EPM – – Lagunas et al., 2010
Wistar rats/12 ne/EPM – – de Chaves et al., 2009
Wistar rats/60 Inline graphic/EPM – – de Chaves et al., 2009
Long-Evans rats/1 Inline graphic/DBT 4 mg/kg P
10 μg/rat E2		 P reduces anxiety-like behavior, E2 without effect Llaneza and Frye, 2009
Sprague-Dawley rats/2 ne/EPM 6 μM/rat Allo ne Laconi et al., 2001
Sprague-Dawley rats/2 Inline graphic/EPM 25 mg/kg P
10 μg/kg E2B		 ne Díaz-Véliz et al., 1997
Wistar rats/3 Inline graphic/LDB 1 mg/kg DZ Reduces anxiety-like behavior Zuluaga et al., 2005
Wistar rats/3, 12 Inline graphic/DBT 0.5, 1, and 2 mg/kg DZ
0.5 and 0.50 mg/kg 8-OH-DPAT		 Both treatments reduce anxiety-like behavior Picazo et al., 2006
Wistar rats/4 Inline graphic/EPM 10 μg/kg E2
10 mg/kg Flx		 E2 reduces anxiety-like behavior, Flx without effect Charoenphandhu et al., 2011
Wistar rats/4 Inline graphic/OFT 150 μg/rat/week E2 Reduces anxiety-like behavior Diz-Chaves et al., 2012
Wistar rats/8 Inline graphic/EPM 0.09 mg/kg E2 Reduces anxiety-like behavior Puga-Olguín et al., 2019
Wistar rats/12 Inline graphic/EPM 0.5, 1, 2, and 4 mg/kg Chry Only 1, 2, and 4 mg/kg Chry reduce anxiety-like behavior Rodríguez-Landa et al., 2019
Wistar rats/12 Inline graphic/LDB 0.25, 0.5, and 1 mg/kg Gen Reduces anxiety-like behavior Rodríguez-Landa et al., 2009
Wistar rats/12 Inline graphic/LDB 2 mg/kg Dz Reduces anxiety-like behavior Rodríguez-Landa et al., 2019
Wistar rats/12 Inline graphic/EPM 0.45, 0.09, and 0.18 mg/kg E2 and Gen Only 0.09 and 0.18 mg/kg reduce anxiety-like
behavior		 Rodríguez-Landa et al., 2017
Effects of ovariectomy and antidepressant substances on depression-like behavior
Animal/Weeks post-OVX OVX effect/Test Treatment Treatment effect Inline graphic References
C57BL/6 mice/2 ne/CUS+FST – – Lagunas et al., 2010
C57BL/6 mice/2 ne/FST
Inline graphic/TST		 – – Carrier et al., 2015
Wistar rats/1, 3 ne/FST – – Puga-Olguín et al., 2019
Wistar rats/8 ne/FST – – Dornellas et al., 2018
Wistar rats/12, 60 ne/FST – – de Chaves et al., 2009
Wistar rats/6, 9, 12, 15 Inline graphic/FST – – Puga-Olguín et al., 2019
C57BL/6 mice/16 Inline graphic/CUMS+FST – – Lagunas et al., 2010
C57BL/6 mice /1-2 ne/TST 10 mg/kg P Reduces depression-like behavior Frye, 2011
Wistar rats/2 ne/FST 0.8, 1.6, and 3.0 mg/kg P Reduces depression-like behavior Martínez-Mota et al., 1999
Wistar rats/2 Inline graphic/FST 0.3, 1, and 3 μg/rat E2 and 0.6 mg/rat Map Reduces depression-like behavior Okada et al., 1997
Wistar rats/2 Inline graphic/FST 1 mg/kg P, Allo, Chry Reduces depression-like behavior Cueto-Escobedo et al., 2020
Wistar rats/7 Inline graphic/FST 150 μg/rat/week E2 Reduces depression-like behavior Diz-Chaves et al., 2012
Wistar rats/8 Inline graphic/FST 0.09 mg/kg E2 Reduces depression-like behavior Puga-Olguín et al., 2019
Wistar rats/8 Inline graphic/FST 0.5, 1, and 2 mg/kg P Only 1 and 2 mg/kg P reduce depression-like behavior Rodríguez-Landa et al., 2020
ICR mice/8 Inline graphic/FST
/TST		 1 μg/kg E2 and 100 mg/kg Pue Both treatments reduce depression-like behavior Tantipongpiradet et al., 2019
Wistar rats/8 Inline graphic/FST 5 mg/kg P Reduces depression-like behavior Rodríguez-Landa et al., 2020
Wistar rats/9 Inline graphic/FST 25 μg/day/6 weeks E2 Reduces depression-like behavior Khayum et al., 2020
Wistar rats/12 ne/FST 0.25 mg/rat E2 ne Boldarine et al., 2019
Open in a new tab

Behavioral tests: CUS, chronic unpredictable stress; OFT, open field test; DBT, defensive burying test; LDB, light/dark box; FST, forced swim test; TST, tail suspension test. Evaluated substances: E2, estradiol; E2B, estradiol benzoate; P, progesterone; Allo, neurosteroid allopregnanolone; Flx, fluoxetine; Map, maprotiline; Dz, diazepam; Chry, flavonoid chrysin; Gen, isoflavone genistein; Pue, isoflavone puerarin. Effects of timing post-ovariectomy: ne, no effects on anxiety- or depression-like behaviors; Inline graphic, OVX increase anxiety-like behavior by decreasing time in open arms and increasing anxiety index; Inline graphic, OVX increase anxiety-like behavior by decreasing time in open arms; Inline graphic, OVX increase anxiety-like behavior by increasing time spent burying; Inline graphic, OVX increase anxiety-like behavior by decreasing time spent in light compartment; Inline graphic, OVX increase anxiety-like behavior in aged rats by decreasing time in central areas; Inline graphic, OVX increase depression-like behavior by increasing total time of immobility; Inline graphicAnxiety- and depression-like behaviors are reduced when treatment produce the contrary effect on the variable described in the second column of the table (indicated by the different arrow colors). OVX, ovariectomy.

Ovarian hormones, estradiol, and progesterone, regulate several neurochemical processes in brain structures involved in the physiopathology of anxiety and depression, such as the prefrontal cortex, hypothalamus, amygdala, septal nucleus, and hippocampus (Giannini et al., 2021). Studies among laboratory animals and humans have reported that progesterone and its reduced metabolite allopregnanolone target the GABAA receptor and facilitate the activation of the GABAergic system, which can modulate dopaminergic and serotonergic pathways (Chen et al., 2021), producing anxiolytic- and antidepressant-like effects (Fernández-Guasti and Picazo, 1995; Estrada-Camarena et al., 2002; Frye and Walf, 2002; Rodríguez-Landa et al., 2007). Estrogen appears to mediate anxiety- and depression-like behavior by stimulating tryptophan hydroxylase, the rate-limiting enzyme in the synthesis of serotonin (Bethea et al., 2000; Giannini et al., 2021). In rats, estrogen also mediates the regulation of the 5-hydroxytryptamine-1A (5-HT1A) receptor expression in the dorsal raphe nucleus. Furthermore, it increases the density of postsynaptic 5-HT2 receptors in the forebrain (Sumner et al., 1999), thereby affecting the receptors involved in the neurobiology of depressive disorders and the mechanisms of action of antidepressant drugs (García-Ríos et al., 2017).

Interestingly, at 1 week post-ovariectomy in rats, there was a reduction in the activation of glutamatergic receptors in the basolateral amygdala (De Jesús-Burgos et al., 2012), a structure involved in the regulation of anxiety. At 1–2 weeks post-ovariectomy, a critical reduction of dendritic spines and synaptophysin density occurred in the pyramidal neurons of the CA1 layer of the hippocampus in rats (Velázquez-Zamora et al., 2012), negatively impacting neuronal communication and the regulation of emotional and cognitive processes. This reduction in dendritic spine density in CA1 also occurs in rats at 3 weeks post-ovariectomy (McLaughlin et al., 2008). It is important to note that neurochemical changes in the brain are dependent on the post-ovariectomy time frame. In this way, after 4 weeks post-ovariectomy, genomic changes occur in the brain structures involved in the neurobiology of anxiety and depression. As studied in rats, the mRNA expression of the α-2 and α-3 subunits of the amygdala GABAA receptor (De Jesús-Burgos et al., 2012) was reduced, along with tryptophan hydroxylase mRNA, and serotonergic transporter mRNA of the dorsal raphe nucleus (Charoenphandhu et al., 2011). In addition, the concentration of serotonin in the hippocampus and nucleus accumbens (Pandaranandaka et al., 2009) is reduced. Additionally, other neurochemical and molecular changes appear post-ovariectomy. It is noteworthy that all these changes are reported from 4 weeks post-ovariectomy, but it is unknown whether these changes occur earlier than 4 weeks post-ovariectomy, which remains to be explored.

Five weeks after ovariectomy in mice, there is a reduced thickness of the CA1 layer in the hippocampus and the cerebral prefrontal cortex (Xu and Zhang, 2006). While 6 weeks after ovariectomy in rats, there is a reduction in the dopamine concentration in the central nucleus of the amygdala (Izumo et al., 2012) and a significant reduction in the expression of Fos protein immunoreactivity in the dorsal, intermediate, and ventral areas of the lateral septum. However, this was negatively correlated with anxiety- and depression-like behavior (Puga-Olguín et al., 2019). Interestingly, at 8 and 9 weeks post-ovariectomy, a reduced expression of estrogen receptors (ER), αER and βER mRNA was detected in the hippocampus and cerebral cortex along with a reduced density of dendritic spines in the cerebral cortex of rats (Jin et al., 2005).

All these data clearly show that ovariectomy in mice and rats produces significant neuroanatomical and neurochemical changes in brain structures involved in the physiopathology of anxiety and depression, in which anxiolytic and antidepressant drugs play a contributory role, similar to women experiencing early surgical menopause (Kingsberg et al., 2020; Georgieva et al., 2021). Although few studies have correlated neurochemical and neuroanatomical changes that occur in ovariectomy with anxiety- and depression-like behaviors, these results support that long-term ovariectomy can be a useful tool to evaluate the neurobiological substrates that underlie anxiety- and depression-like behaviors associated with a reduced concentration of ovarian hormones induced by surgical menopause. Further, consideration of these factors will aid in studying the effect of new compounds with potential anxiolytic and antidepressant activity in women whose ovaries are removed.

Evaluation of Anxiety- and Depression-Like Behavior Associated with Long Term Ovariectomy: Effects of Anxiolytic and Antidepressant Drugs

Long-term ovariectomy in mice and rats increases the incidence of anxiety-like behavior in behavioral tests of anxiety, such as the elevated plus maze (EPM), open field test, burying defensive test, and light/dark box, as presented in Table 1. In the EPM, ovariectomy decreases the time spent into the open arms, which is considered as higher anxiety and depends on the time post-ovariectomy (Puga-Olguín et al., 2019). Contrarily, anxiolytic drugs like diazepam, hormones like progesterone and estradiol, or natural products like flavonoids, significantly increase the time in the open arms, thereby producing anxiolytic effects (Charoenphandhu et al., 2011; Rodríguez-Landa et al., 2017, 2019). Similar effects are observed in the other behavioral tests for anxiety. Ovariectomy reduces the time spent in the area where anxiogenic stimuli are present, and this time increases when anxiolytic drugs are injected to mice or rats, such as diazepam, estradiol, progesterone, allopregnanolone, or phytoestrogen genistein (Picazo et al., 2006; Llaneza and Frye, 2009; Rodríguez-Landa et al., 2009; Diz-Chaves et al., 2012).

Ovariectomy also increases the incidence of depression-like behavior in some animal models to evaluate despair behavior, including the tail suspension test (TST), forced swim test (FST), and chronic unpredictable stress (CUS). In the TST and FST, ovariectomy increases the time of immobility depending on the time-post ovariectomy (Lagunas et al., 2010; Puga-Olguín et al., 2019), which is considered as an indicator of depression-like behavior. Interestingly, ovariectomized mice and rats treated with antidepressant drugs like maprotiline, or some hormones like progesterone, allopregnanolone, and estradiol, had reduced time of immobility among other behavioral variables (Okada et al., 1997; Tantipongpiradet et al., 2019; Cueto-Escobedo et al., 2020; Khayum et al., 2020; Rodríguez-Landa et al., 2020), which is considered as an antidepressant-like effect. In the particular case of CUS, rats are subjected to several stressors for 4 weeks, which subsequently produces depression-like behavior identified by an increase in the time of immobility in the FST (Lagunas et al., 2010). This effect is dependent on the time post-ovariectomy, which was higher at 20 weeks than at 6 weeks post-ovariectomy. This shows that time post-ovariectomy is an important variable that should be considered in studying the effects of ovariectomy on anxiety- and depression-like behavior, and their potential treatments.

Concluding Remarks

Studying the effect of the long-term absence of ovarian hormone produced by ovariectomy in mice and rats on anxiety- and depression-like behaviors and the underlying neurochemical and anatomical changes is necessary in understanding neuropsychiatric disorders among women undergoing oophorectomy. Considering that in experimental animals, it is possible to discard the socio-cultural influence that menopause could have on women and its contribution to their emotional and affective disorders (Afridi, 2017; Zhang et al., 2019), the surgical menopause model in mice and rats may provide new evidence for the neurobiological mechanism resulting from ovariectomy (oophorectomy in women) in the long-term. Therefore, this model can be used to explore potential therapeutic strategies to ameliorate emotional and affective symptoms, in addition to physiological, histological, structural, and neuropsychiatric disorders occurring in women subjected to surgical menopause.

As mentioned above, the time elapsed after ovariectomy in rats plays a significant role in the expression of anxiety- and depression-like behavior, and possibly in the effects produced by anxiolytic and antidepressant drugs. Therefore, it is important to consider the time post-ovariectomy when we use such procedure to explore anxiety- and depression-like behavior or potential anxiolytic or antidepressant drugs. Additionally, including control groups of non-ovariectomized rats or referring to the control groups in previously published studies would ensure suitable comparations to progress our research. This would help in enhancing the understanding of behavioral changes associated with surgical menopause and help develop potential pharmacological strategies to ameliorate the negative effects produced by long-term ovariectomy. The model also allows consideration of the post-ovariectomy time frame to achieve better control of the evaluated variables and ensure the reproducibility and comparison of results.

Author Contributions

JFR-L conceived and wrote this article.

Funding

This article is part of the SIREI project (DGI: 266502020108) registered by JFR-L, with partial financial support from the Sistema Nacional de Investigadores (SNI, Exp. 32753), CONACyT, Mexico.

Conflict of Interest

The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Acknowledgments

The author would like to thank the reviewers and the editor for their suggestions and comments that greatly contributed to improving this article. Additionally, the author would like to thank Editage (www.editage.com) for English language editing.

References

  1. Afridi I. (2017). Psychological and social aspects of menopause, in A Multidisciplinary Look at Menopause, eds Rodríguez-Landa J. F., Cueto-Escobedo J. (Rijeka: Intech; ), 49–61. 10.5772/intechopen.69078 [DOI] [Google Scholar]
  2. Alagwu E. A., Nneli R. O. (2005). Effect of ovariectomy on the level of plasma sex hormones in albino rats. Niger J. Physiol. Sci. 20, 90–94. [PubMed] [Google Scholar]
  3. Albert K., Pruessner J., Newhouse P. (2015). Estradiol levels modulate brain activity and negative responses to psychosocial stress across the menstrual cycle. Psychoneuroendocrinology 59, 14–24. 10.1016/j.psyneuen.2015.04.022 [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bethea C. L., Gundlah C., Mirkes S. J. (2000). Ovarian steroid action in the serotonin neural system of macaques. Novartis Found. Symp. 230, 112–130. 10.1002/0470870818.ch9 [DOI] [PubMed] [Google Scholar]
  5. Boldarine V. T., Pedroso A. P., Neto N. I. P., Dornellas A. P. S., Nascimento C. M. O., Oyama L. M., et al. (2019). High-fat diet intake induces depressive-like behavior in ovariectomized rats. Sci. Rep. 9:10551. 10.1038/s41598-019-47152-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bronson F. H. (1976). Serum, FSH, LH, and prolactin in adult ovariectomized mice bearing silastic implants of estradiol: responses to social cues. Biol. Reprod. 15, 147–152. 10.1095/biolreprod15.2.147 [DOI] [PubMed] [Google Scholar]
  7. Burger H. G., Hale G. E., Robertson D. M., Dennerstein L. (2007). A review of hormonal changes during the menopausal transition: focus on findings from the Melbourne Women's Midlife Health Project. Hum. Reprod. Update 13, 559–565. 10.1093/humupd/dmm020 [DOI] [PubMed] [Google Scholar]
  8. Canuas-Landero V. G., George C. N., Lefley D. V., Corness H., Muthana M., Wilson C., et al. (2021). Oestradiol contributes to differential antitumour effects of adjuvant zoledronic acid observed between pre- and post-menopausal women. Front. Endocrinol. 12:749428. 10.3389/fendo.2021.749428 [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Carrier N., Wang X., Sun L., Lu X. Y. (2015). Sex-specific and estrous cycle-dependent antidepressant-like effects and hippocampal Akt signaling of leptin. Endocrinology 156, 3695–3705. 10.1210/EN.2015-1029 [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Chandrashekar V., Bartke A. (1996). Influence of hypothalamus and ovary on pituitary function in transgenic mice expressing the bovine growth hormone gene and in growth hormone-deficient Ames dwarf mice. Biol. Reprod. 54, 1002–1008. 10.1095/biolreprod54.5.1002 [DOI] [PubMed] [Google Scholar]
  11. Charoenphandhu J., Teerapornpuntakit J., Nuntapornsak A., Krishnamra N., Charoenphandhu N. (2011). Anxiety-like behaviors and expression of SERT and TPH in the dorsal raphe of estrogen- and fluoxetine-treated ovariectomized rats. Pharmacol. Biochem. Behav. 98, 503–510. 10.1016/j.pbb.2011.02.023 [DOI] [PubMed] [Google Scholar]
  12. Chen S., Gao L., Li X., Ye Y. (2021). Allopregnanolone in mood disorders: mechanism and therapeutic development. Pharmacol. Res. 169:105682. 10.1016/j.phrs.2021.105682 [DOI] [PubMed] [Google Scholar]
  13. Chung-Park M. (2006). Anxiety attacks following surgical menopause. Nurse Pract. 31, 44–49. 10.1097/00006205-200605000-00008 [DOI] [PubMed] [Google Scholar]
  14. Cueto-Escobedo J., Andrade-Soto J., Lima-Maximino M., Maximino C., Hernández-López F., Rodríguez-Landa J. F. (2020). Involvement of GABAergic system in the antidepressant-like effects of chrysin (5,7-dihydroxyflavone) in ovariectomized rats in the forced swim test: comparison with neurosteroids. Behav. Brain Res. 386:112590. 10.1016/j.bbr.2020.112590 [DOI] [PubMed] [Google Scholar]
  15. de Chaves G., Moretti M., Castro A. A., Dagostin W., da Silva G. G., Boeck C. R., et al. (2009). Effects of long-term ovariectomy on anxiety and behavioral despair in rats. Physiol. Behav. 97, 420–425. 10.1016/j.physbeh.2009.03.016 [DOI] [PubMed] [Google Scholar]
  16. De Jesús-Burgos M., Torres-Llenza V., Pérez-Acevedo N. L. (2012). Activation of amygdalar metabotropic glutamate receptors modulates anxiety, and risk assessment behaviors in ovariectomized estradiol-treated female rats. Pharmacol. Biochem. Behav. 101, 369–378. 10.1016/j.pbb.2012.01.016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Díaz-Véliz G., Alarcón T., Espinoza C., Dussaubat N., Mora S. (1997). Ketanserin and anxiety levels: influence of gender, estrous cycle, ovariectomy and ovarian hormones in female rats. Pharmacol. Biochem. Behav. 58, 637–642. 10.1016/S0091-3057(97)90004-6 [DOI] [PubMed] [Google Scholar]
  18. Diz-Chaves Y., Kwiatkowska-Naqvi A., Von Hülst H., Pernía O., Carrero P., Garcia-Segura L. M. (2012). Behavioral effects of estradiol therapy in ovariectomized rats depend on the age when the treatment is initiated. Exp. Gerontol. 47, 93–99. 10.1016/j.exger.2011.10.008 [DOI] [PubMed] [Google Scholar]
  19. Dornellas A. P. S., Boldarine V. T., Pedroso A. P., Carvalho L. O. T., de Andrade I. S., Vulcani-Freitas T. M., et al. (2018). High-fat feeding improves anxiety-type behavior induced by ovariectomy in rats. Front. Neurosci. 12:557. 10.3389/fnins.2018.00557 [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Estrada-Camarena E., Contreras C. M., Saavedra M., Luna-Baltazar I., López-Rubalcava C. (2002). Participation of the lateral septal nuclei (LSN) in the antidepressant-like actions of progesterone in the forced swimming test (FST). Behav. Brain Res. 134, 175–183. 10.1016/S0166-4328(02)00023-2 [DOI] [PubMed] [Google Scholar]
  21. Fedotova J., Dudnichenko T., Kruzliak P., Puchavskaya Z. (2016). Different effects of vitamin D hormone treatment on depression-like behavior in the adult ovariectomized female rats. Biomed. Pharmacother. 84, 1865–1872. 10.1016/j.biopha.2016.10.107 [DOI] [PubMed] [Google Scholar]
  22. Fernández-Guasti A., Picazo O. (1995). Flumazenil blocks the anxiolytic action of allopregnanolone. Eur. J. Pharmacol. 281, 113–115. 10.1016/0014-2999(95)00311-8 [DOI] [PubMed] [Google Scholar]
  23. Frye C. A. (2011). Progesterone reduces depressive behavior of young ovariectomized, aged progestin receptor knockout, and aged wild type mice in the tail suspension test. J. Psychopharmacol. 25, 421–428. 10.1177/0269881109349836 [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Frye C. A., Walf A. A. (2002). Changes in progesterone metabolites in the hippocampus can modulate open field and forced swim test behavior of proestrous rats. Horm Behav. 41, 306–315. 10.1006/hbeh.2002.1763 [DOI] [PubMed] [Google Scholar]
  25. Galeeva A., Tuohimaa P. (2001). Analysis of mouse plus-maze behavior modulated by ovarian steroids. Behav. Brain Res. 119, 41–47. 10.1016/S0166-4328(00)00341-7 [DOI] [PubMed] [Google Scholar]
  26. García-Ríos R. I., Mora-Pérez A., Soria-Fregozo C. (2017). Depression and serotonergic changes during the climacteric and postmenopause stags: hormonal influences, in A Multidisciplinary Look at Menopause, eds Rodríguez-Landa J. F., Cueto-Escobedo J. (Rijeka: Intech; ), 63–80. 10.5772/intechopen.69786 [DOI] [Google Scholar]
  27. Georgieva A., Eftimov M., Todorova M., Kuzmanova V., Kuzmanov A., Kuzmanov K., et al. (2021). Effects of ovariectomy-induced estrogen deficit on rat behaviour, lipid metabolism, inflammation, bone mineral density, and turnover. Folia Med. 63, 385–391. 10.3897/folmed.63.e55267 [DOI] [PubMed] [Google Scholar]
  28. Giannini A., Caretto M., Genazzani A. R., Simoncini T. (2021). Neuroendocrine changes during menopausal transition. Endocrines 2, 405–416. 10.3390/endocrines2040036 [DOI] [Google Scholar]
  29. Hiroi R., Neumaier J. F. (2006). Differential effects of ovarian steroids on anxiety versus fear as measured by open field test and fear-potentiated startle. Behav. Brain Res. 166, 93–100. 10.1016/j.bbr.2005.07.021 [DOI] [PubMed] [Google Scholar]
  30. Huerta R., Mena A., Malacara J. M., de León J. D. (1995). Symptoms at the menopausal and premenopausal years: their relationship with insulin, glucose, cortisol, FSH, prolactin, obesity and attitudes towards sexuality. Psychoneuroendocrinology 20, 851–864. 10.1016/0306-4530(95)00030-5 [DOI] [PubMed] [Google Scholar]
  31. Izumo N., Ishibashi Y., Ohba M., Morikawa T., Manabe T. (2012). Decreased voluntary activity and amygdala levels of serotonin and dopamine in ovariectomized rats. Behav. Brain Res. 227, 1–6. 10.1016/j.bbr.2011.10.031 [DOI] [PubMed] [Google Scholar]
  32. Jin M., Jin F., Zhang L., Chen Z., Huang H. (2005). Two estrogen replacement therapies differentially regulate expression of estrogen receptors alpha and beta in the hippocampus and cortex of ovariectomized rat. Brain Res. Mol. Brain Res. 142, 107–114. 10.1016/j.molbrainres.2005.09.013 [DOI] [PubMed] [Google Scholar]
  33. Khayum M. A., Moraga-Amaro R., Buwalda B., Koole M., den Boer J. A., Dierckx R. A. J. O., et al. (2020). Ovariectomy-induced depressive-like behavior and brain glucose metabolism changes in female rats are not affected by chronic mild stress. Psychoneuroendocrinology 115:104610. 10.1016/j.psyneuen.2020.104610 [DOI] [PubMed] [Google Scholar]
  34. Kingsberg S. A., Larkin L. C., Liu J. H. (2020). Clinical effects of early or surgical menopause. Obstet. Gynecol. 135, 853–868. 10.1097/AOG.0000000000003729 [DOI] [PubMed] [Google Scholar]
  35. Laconi M. R., Casteller G., Gargiulo P. A., Bregonzio C., Cabrera R. J. (2001). The anxiolytic effect of allopregnanolone is associated with gonadal hormonal status in female rats. Eur. J. Pharmacol. 417, 111–116. 10.1016/S0014-2999(01)00865-2 [DOI] [PubMed] [Google Scholar]
  36. Lagunas N., Calmarza-Font I., Diz-Chaves Y., Garcia-Segura L. M. (2010). Long-term ovariectomy enhances anxiety and depressive-like behaviors in mice submitted to chronic unpredictable stress. Horm. Behav. 58, 786–791. 10.1016/j.yhbeh.2010.07.014 [DOI] [PubMed] [Google Scholar]
  37. Lee E., Jang M., Lim T. G., Kim T., Ha H., Lee J. H., et al. (2020). Selective activation of the estrogen receptor-β by the polysaccharide from Cynanchum wilfordii alleviates menopausal syndrome in ovariectomized mice. Int. J. Biol. Macromol. 165, 1029–1037. 10.1016/j.ijbiomac.2020.09.165 [DOI] [PubMed] [Google Scholar]
  38. Li L. H., Wang Z. C., Yu J., Zhang Y. Q. (2014). Ovariectomy results in variable changes in nociception, mood and depression in adult female rats. PLoS ONE 9:e94312. 10.1371/journal.pone.0094312 [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Llaneza D. C., Frye C. A. (2009). Progestogens and estrogen influence impulsive burying and avoidant freezing behavior of naturally cycling and ovariectomized rats. Pharmacol. Biochem. Behav. 93, 337–342. 10.1016/j.pbb.2009.05.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Marcondes F. K., Miguel K. J., Melo L. L., Spadari-Bratfisch R. C. (2001). Estrous cycle influences the response of female rats in the elevated plus-maze test. Physiol. Behav. 74, 435–440. 10.1016/S0031-9384(01)00593-5 [DOI] [PubMed] [Google Scholar]
  41. Martínez-Mota L., Contreras C. M., Saavedra M. (1999). Progesterone reduces immobility in rats forced to swim. Arch. Med. Res. 30, 286–289. 10.1016/S0188-0128(99)00024-X [DOI] [PubMed] [Google Scholar]
  42. McLaughlin K. J., Bimonte-Nelson H., Neisewander J. L., Conrad C. D. (2008). Assessment of estradiol influence on spatial tasks and hippocampal CA1 spines: evidence that the duration of hormone deprivation after ovariectomy compromises 17β-estradiol effectiveness in altering CA1 spines. Horm. Behav. 54, 386–395. 10.1016/j.yhbeh.2008.04.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Moiety F. M., Salem H. A., Mehanna R. A., Abdel-Ghany B. S. (2015). Comparative study on induction and effects of surgical menopause in a female rat model: a prospective case control study. Int. J. Clin. Exp. Med. 8, 9403–9411. [PMC free article] [PubMed] [Google Scholar]
  44. Monteleone P., Mascagni G., Giannini A., Genazzani A. R., Simoncini T. (2018). Symptoms of menopause - global prevalence, physiology and implications. Nat. Rev. Endocrinol. 14, 199–215. 10.1038/nrendo.2017.180 [DOI] [PubMed] [Google Scholar]
  45. Okada M., Hayashi N., Kometani M., Nakao K., Inukai T. (1997). Influences of ovariectomy and continuous replacement of 17β-estradiol on the tail skin temperature and behavior in the forced swimming test in rats. Jpn. J. Pharmacol. 73, 93–96. 10.1254/jjp.60.93 [DOI] [PubMed] [Google Scholar]
  46. Olmos-Vázquez O. J., Rovirosa-Hernández M. J., Pulido-Criollo F., Soria-Fregozo C., Thangavel P., Rodríguez-Landa J. F. (2020). Antidepressant effects of fluoxetine in natural and surgical menopause: preclinical and clinical research, in Advance in Medicine and Biology, ed Berhardt L. V. (New York, NY: Nova Science Publisher; ), 139–170. [Google Scholar]
  47. Pandaranandaka J., Poonyachoti S., Kalandakanond-Thongsong S. (2009). Differential effects of exogenous and endogenous estrogen on anxiety as measured by elevated T-maze in relation to the serotonergic system. Behav. Brain. Res. 198, 142–148. 10.1016/j.bbr.2008.10.043 [DOI] [PubMed] [Google Scholar]
  48. Park B. W., Pan B., Toms D., Huynh E., Byun J. H., Lee Y. M., et al. (2014). Ovarian-cell-like cells from skin stem cells restored estradiol production and estrus cycling in ovariectomized mice. Stem Cells Dev. 23, 1647–1658. 10.1089/scd.2014.0029 [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Picazo O., Estrada-Camarena E., Hernández-Aragon A. (2006). Influence of the post-ovariectomy time frame on the experimental anxiety and the behavioural actions of some anxiolytic agents. Eur. J. Pharmacol. 530, 88–94. 10.1016/j.ejphar.2005.11.024 [DOI] [PubMed] [Google Scholar]
  50. Puga-Olguín A., Rodríguez-Landa J. F., Rovirosa-Hernández M. J., Germán-Ponciano L. J., Caba M., Meza E., et al. (2019). Long-term ovariectomy increases anxiety- and despair-like behaviors associated with lower Fos immunoreactivity in the lateral septal nucleus in rats. Behav. Brain Res. 360, 185–195. 10.1016/j.bbr.2018.12.017 [DOI] [PubMed] [Google Scholar]
  51. Ratka A., Simpkins J. W. (1990). Dose-dependent effects of chronic treatment with estradiol or progesterone on LH secretion in ovariectomized rats. Endocr. Res. 16, 165–184. 10.1080/07435809009032997 [DOI] [PubMed] [Google Scholar]
  52. Rocca W. A., Grossardt B. R., Geda Y. E., Gostout B. S., Bower J. H., Maraganore D. M., et al. (2018). Long-term risk of depressive and anxiety symptoms after early bilateral oophorectomy. Menopause 25, 1275–1285. 10.1097/GME.0000000000001229 [DOI] [PubMed] [Google Scholar]
  53. Rodin D. A., Abbot S. D., Saade G., Clayton R. N. (1990). Comparison of the pretranslational regulation of FSH synthesis by gonadal steroids in rats and mice. J. Mol. Endocrinol. 4, 159–167. 10.1677/jme.0.0040159 [DOI] [PubMed] [Google Scholar]
  54. Rodríguez-Landa J. F., Contreras C. M., Bernal-Morales B., Gutiérrez-García A. G., Saavedra M. (2007). Allopregnanolone reduces immobility in the forced swimming test and increases the firing rate of lateral septal neurons through actions on the GABAA receptor in the rat. J. Psychopharmacol. 21, 76–84. 10.1177/0269881106064203 [DOI] [PubMed] [Google Scholar]
  55. Rodríguez-Landa J. F., Cueto-Escobedo J., Puga-Olguín A., Rivadeneyra-Domínguez E., Bernal-Morales B., Herrera-Huerta E. V., et al. (2017). The phytoestrogen genistein produces similar effects as 17β-estradiol on anxiety-like behavior in rats at 12 weeks after ovariectomy. Biomed. Res. Int. 2017:9073816. 10.1155/2017/9073816 [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Rodríguez-Landa J. F., Hernández-Figueroa J. D., Hernández-Calderón B. C., Saavedra M. (2009). Anxiolytic-like effect of phytoestrogen genistein in rats with long-term absence of ovarian hormones in the black and white model. Prog. Neuropsychopharmacol. Biol. Psychiatry 33, 367–372. 10.1016/j.pnpbp.2008.12.024 [DOI] [PubMed] [Google Scholar]
  57. Rodríguez-Landa J. F., Hernández-López F., Cueto-Escobedo J., Herrera-Huerta E. V., Rivadeneyra-Domínguez E., Bernal-Morales B., et al. (2019). Chrysin (5,7-dihydroxyflavone) exerts anxiolytic-like effects through GABAA receptors in a surgical menopause model in rats. Biomed. Pharmacother. 109, 2387–2395. 10.1016/j.biopha.2018.11.111 [DOI] [PubMed] [Google Scholar]
  58. Rodríguez-Landa J. F., Olmos-Vázquez O. J., Dutra da Costa B. P., Lima-Maximino M., Maximino C., Guillén-Ruiz G. (2020). Actions of progesterone on depression-like behavior in a model of surgical menopause are mediated by GABAA receptors. Salud Mental 43, 43–53. 10.17711/SM.0185-3325.2020.007 [DOI] [Google Scholar]
  59. Rodríguez-Landa J. F., Puga-Olguín A., Germán-Ponciano L. J., García-Ríos R. I., Soria-Fregozo C. (2015). Anxiety in natural and surgical menopause: physiologic and therapeutic bases, in A Fresh Look at Anxiety Disorders, ed Durbano F. (Rijeka: Intech; ), 173–198. 10.5772/60621 [DOI] [Google Scholar]
  60. Smith S. S., Gong Q. H., Li X., Moran M. H., Bitran D., Frye C. A., et al. (1998). Withdrawal from 3α-OH-5α-pregnan-20-one using a pseudopregnancy model alters the kinetics of hippocampal GABAA-gated current and increases the GABAA receptor α4 subunit in association with increased anxiety. J. Neurosci. 18, 5275–5284. 10.1523/JNEUROSCI.18-14-05275.1998 [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Sumner B. E., Grant K. E., Rosie R., Hegele-Hartung C., Fritzemeier K. H., Fink G. (1999). Effects of tamoxifen on serotonin transporter and 5-hydroxytryptamine(2A) receptor binding sites and mRNA levels in the brain of ovariectomized rats with or without acute estradiol replacement. Brain Res. Mol. Brain Res. 73, 119–128. 10.1016/S0169-328X(99)00243-0 [DOI] [PubMed] [Google Scholar]
  62. Tantipongpiradet A., Monthakantirat O., Vipatpakpaiboon O., Khampukdee C., Umehara K., Noguchi H., et al. (2019). Effects of puerarin on the ovariectomy-induced depressive-like behavior in ICR mice and its possible mechanism of action. Molecules 24:4569. 10.3390/molecules24244569 [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Velázquez-Zamora D. A., González-Tapia D., González-Ramírez M. M., Flores-Soto M. E., Vázquez-Valls E., Cervantes M., et al. (2012). Plastic changes in dendritic spines of hippocampal CA1 pyramidal neurons from ovariectomized rats after estradiol treatment. Brain Res. 1470, 1–10. 10.1016/j.brainres.2012.06.012 [DOI] [PubMed] [Google Scholar]
  64. Wise P. M., Ratner A. (1980). Effect of ovariectomy on plasma LH, FSH, estradiol, and progesterone and medial basal hypothalamic LHRH concentrations old and young rats. Neuroendocrinology 30, 15–19. 10.1159/000122968 [DOI] [PubMed] [Google Scholar]
  65. Xu M., Hill J. W., Levine J. E. (2000). Attenuation of luteinizing hormone surges in neuropeptide Y knockout mice. Neuroendocrinology 72, 263–271. 10.1159/000054595 [DOI] [PubMed] [Google Scholar]
  66. Xu X., Zhang Z. (2006). Effects of estradiol benzoate on learning-memory behavior and synaptic structure in ovariectomized mice. Life Sci. 79, 1553–1560. 10.1016/j.lfs.2006.04.020 [DOI] [PubMed] [Google Scholar]
  67. Zakaria R., Rahbi B. A., Ahmad A. H., Said R. M., Othman Z., Azman K. F., et al. (2019). Menopause rodent models: suitability for cognitive aging research. Int. Med. J. 26, 450–452. [Google Scholar]
  68. Zhang Y., Zhao X., Leonhart R., Nadig M., Wang J., Zhao Y., et al. (2019). A cross-cultural comparison of climacteric symptoms, health-seeking behavior, and attitudes towards menopause among Mosuo women and Han Chinese women in Yunnan, China. Transcult. Psychiatry 56, 287–301. 10.1177/1363461518804094 [DOI] [PubMed] [Google Scholar]
  69. Zhao H., Tian Z., Hao J., Chen B. (2005). Extragonadal aromatization increases with time after ovariectomy in rats. Reprod. Biol. Endocrinol. 3:6. 10.1186/1477-7827-3-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Zoladz P. R., D'Alessio P. A., Seeley S. L., Kasler C. D., Goodman C. S., Mucher K. E., et al. (2019). A predator-based psychosocial stress animal model of PTSD in females: influence of estrous phase and ovarian hormones. Horm. Behav. 115:104564. 10.1016/j.yhbeh.2019.104564 [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Zsakai A., Karkus Z., Utczas K., Biri B., Sievert L. L., Bodzsar E. B. (2016). Body fatness and endogenous sex hormones in the menopausal transition. Maturitas 87, 18–26. 10.1016/j.maturitas.2016.02.006 [DOI] [PubMed] [Google Scholar]
  72. Zuluaga M. J., Agrati D., Pereira M., Uriarte N., Fernández-Guasti A., Ferreira A. (2005). Experimental anxiety in the black and white model in cycling, pregnant and lactating rats. Physiol. Behav. 84, 279–286. 10.1016/j.physbeh.2004.12.004 [DOI] [PubMed] [Google Scholar]

Articles from Frontiers in Behavioral Neuroscience are provided here courtesy of Frontiers Media SA

RESOURCES